Intrauterine Hyaluronic Acid Gel for Prevention of Intrauterine Adhesions

• Status: Active, not recruiting
• Trial end date: 2022-07-25
• Target enrollment: 0
• Participant gender: Female

Summary

Women undergoing operative hysteroscopy for removal of retained placenta after delivery will be randomized into two groups.

1. study group - immediately after operative hysteroscopy 5 ml hyaluronic acid gel will be injected into uterine cavity

2. control group - no injection

4-8 weeks after operative hysteroscopy, participants will undergo diagnostic hysteroscopy with no anesthesia , as a part of routine evaluation after removal of retained placenta in Israel.

during diagnostic hysteroscopy the uterine cavity will be evaluated and the presence of adhesions and severity of adhesions will be recorded.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Barzilai Medical Center
• Treatments: Hyaluronic Acid

Criteria

Inclusion Criteria:

• Women undergoing hysteroscopic removal of retained placenta after delivery

Exclusion Criteria:

• Known adverse reaction or allergy to hyaluronic acid

History of intrauterine adhesions

Acute pelvic inflammatory disease